Workflow
MUPRO IFT.(836422)
icon
Search documents
润普食品(836422) - 2023 Q4 - 年度业绩预告
2024-02-25 16:00
Financial Performance - The company's net profit attributable to shareholders for the reporting period is expected to be 10.77 million yuan, a decrease of 85.37% compared to 73.57 million yuan in the same period last year[2]. - The decline in performance is attributed to economic downturns leading to accelerated destocking in the industry, resulting in weakened short-term demand and increased market competition[3]. Research and Development - The company increased its R&D investment in the sorbic acid project, leading to higher R&D expenses during the reporting period[3]. Selling and Marketing Expenses - Participation in domestic and international exhibitions resulted in increased selling expenses for the company during the reporting period[3]. Inventory Management - The company significantly increased the provision for inventory impairment due to indications of impairment in inventory at the end of the reporting period[3].
润普食品:关于公司使用部分闲置募集资金委托理财进展的公告
2023-11-15 11:46
证券代码:836422 证券简称:润普食品 公告编号:2023-116 江苏润普食品科技股份有限公司 关于公司使用部分闲置募集资金委托理财进展的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 授权委托理财情况 1、审议情况:2023 年 4 月 26 日,公司第三届董事会第十五次会议及第三 届监事会第十三次会议,审议通过了《关于使用闲置募集资金购买理财产品的议 案》,同意公司自 2023 年 4 月 26 日起 12 个月内,使用总额度不超过人民币 6,000 万元的闲置募集资金进行现金管理购买理财产品,在上述额度内,资金可循环滚 动使用,具体议案内容详见公司在北京证券交易所披露平台(www.bse.cn)披露 的《使用部分闲置募集资金购买理财产品的公告》(公告编号:2023-052)。 2、披露标准:根据《北京证券交易所股票上市规则(试行)》中相关规定, 交易的成交金额占上市公司最近一期经审计净资产的 10%以上且超过 1000 万元 的应当予以披露;上市公司连续 12 个月滚动发生理财的 ...
润普食品:第三届监事会第十七次会议决议公告
2023-10-30 08:05
证券代码:836422 证券简称:润普食品 公告编号:2023-113 江苏润普食品科技股份有限公司 第三届监事会第十七次会议决议公告 本公司及监事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 (一)会议召开情况 1.会议召开时间:2023 年 10 月 30 日 2.会议召开地点:公司会议室 3.会议召开方式:现场 4.发出监事会会议通知的时间和方式:2023 年 10 月 20 日以通讯方式发出 5.会议主持人:监事会主席李树军 6.召开情况合法、合规、合章程性说明: 本次会议的召集、召开、议案审议程序符合法律、行政法规、部门规章和《公 司章程》的规定。 (二)会议出席情况 会议应出席监事 3 人,出席和授权出席监事 3 人。 二、议案审议情况 (一)审议通过《关于公司 2023 年第三季度报告的议案》 1.议案内容: 根据《北京证券交易所股票上市规则(试行)》(以下简称"《北交所股票上 市规则》")、《江苏润普食品科技股份有限公司信息披露管理制度》等相关规定和 北京证券交易所《关于做 ...
润普食品:第三届董事会第十九次会议决议公告
2023-10-30 08:05
证券代码:836422 证券简称:润普食品 公告编号:2023-112 江苏润普食品科技股份有限公司 第三届董事会第十九次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 2.会议召开地点:公司会议室 3.会议召开方式:现场与通讯 4.发出董事会会议通知的时间和方式:2023 年 10 月 20 日以通讯方式发出 5.会议主持人:董事长潘如龙 6.开情况合法、合规、合章程性说明: 一、会议召开和出席情况 (一)会议召开情况 1.会议召开时间:2023 年 10 月 30 日 本次会议的召集、召开、议案审议程序符合法律、行政法规、部门规章和《公 司章程》的规定。 (二)会议出席情况 会议应出席董事 8 人,出席和授权出席董事 8 人。 董事聂诗军、肖侠、赵耀华、彭中杰因工作原因以通讯方式参与表决。 二、议案审议情况 (一)审议通过《关于公司 2023 年第三季度报告的议案》 1.议案内容: 根据《北京证券交易所股票上市规则(试行)》(以下简称"《北交所股票上 市规则》")、《江苏润普食品科技股 ...
润普食品:关于公司拟向银行申请综合授信的公告
2023-10-30 08:05
证券代码:836422 证券简称:润普食品 公告编号:2023-115 江苏润普食品科技股份有限公司 二、会议审议和表决情况 公司于 2023 年 10 月 30 日召开第三届董事会第十九次会议,审议通过了《关 于公司拟向中国银行连云港海州支行申请不超过人民币 5000 万元综合授信的议 案》、《关于公司拟向招商银行股份有限公司连云港分行申请不超过人民币 2000 万元综合授信的议案》,上述议案表决情况:同意 8 票,反对 0 票,弃权 0 票。 回避表决情况:议案无需回避表决。上述议案无需提交股东大会审议。 三、本次申请授信额度的必要性及对公司影响 关于拟向银行申请综合授信的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记 载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、综合授信基本情况 为满足生产经营及业务发展需要,江苏润普食品科技股份有限公司(以下简 称"公司")拟向银行申请不超过人民币 7000 万元的综合授信额度。其中拟向 中国银行连云港海州支行申请不超过人民币 5000 万元综合授信、拟向招商银行 股份有限公司连云港分行申请不超过 ...
润普食品(836422) - 2023 Q3 - 季度财报
2023-10-29 16:00
Financial Performance - The company's operating revenue for the first nine months of 2023 was CNY 391,563,628.37, a decrease of 20.21% compared to CNY 490,743,079.33 in the same period last year[10]. - The net profit attributable to shareholders for the first nine months of 2023 was CNY 16,609,125.61, down 72.31% from CNY 59,989,005.57 year-on-year[10]. - The basic earnings per share for the first nine months decreased by 77.27%, from CNY 0.88 to CNY 0.20[10]. - Total operating revenue for the first nine months of 2023 was CNY 391,563,628.37, a decrease from CNY 490,743,079.33 in the same period of 2022, representing a decline of approximately 20.2%[37]. - Net profit for the first nine months of 2023 was CNY 16,609,125.61, significantly lower than CNY 59,989,005.57 in 2022, reflecting a decrease of approximately 72.3%[39]. - Basic and diluted earnings per share for the first nine months of 2023 were CNY 0.20, down from CNY 0.88 in the same period of 2022, a decline of about 77.3%[39]. Assets and Liabilities - The total assets as of September 30, 2023, increased by 12.17% to CNY 538,523,599.16 from CNY 480,083,218.48 at the end of 2022[11]. - The net assets attributable to shareholders rose by 49.37% to CNY 432,476,689.40 compared to CNY 289,536,521.53 at the end of 2022[11]. - Total liabilities decreased to CNY 106,046,909.76 from CNY 190,546,696.95, a reduction of approximately 44.2%[31]. - The company's total liabilities as of the reporting date were CNY 70,939,193.06, compared to CNY 142,151,711.81 in the previous year, showing a decrease of approximately 50%[35]. - The company's total assets amounted to CNY 471,396,128.01, compared to CNY 407,486,842.29 in the previous year, reflecting an increase of approximately 15.6%[35]. Cash Flow - The cash flow from operating activities for the first nine months was CNY 29,525,279.98, a decline of 56.45% from CNY 67,795,629.84 in the previous year[10]. - Operating cash inflow for the first nine months of 2023 was CNY 493,784,267.40, a decrease of 29.0% compared to CNY 695,871,679.73 in the same period of 2022[43]. - Net cash flow from operating activities for the first nine months of 2023 was CNY 29,525,279.98, down 56.5% from CNY 67,795,629.84 in 2022[44]. - Total cash and cash equivalents at the end of September 2023 reached CNY 101,589,888.40, an increase from CNY 59,346,461.11 at the end of 2022[44]. - Cash inflow from financing activities in the first nine months of 2023 was CNY 161,662,226.82, significantly higher than CNY 50,711,429.06 in the same period of 2022[44]. - Net cash flow from investing activities was negative CNY 83,762,801.59 in 2023, compared to negative CNY 24,354,202.64 in 2022, indicating increased investment outflows[44]. Expenses - The company reported a 34.97% increase in selling expenses, totaling CNY 9,849,485.73, primarily due to higher business hospitality and exhibition costs[12]. - Research and development expenses increased by 37.05% to CNY 11,583,958.02, mainly due to increased raw material usage for sorbic acid research[12]. - Total operating costs for the first nine months of 2023 were CNY 373,716,219.15, down from CNY 417,645,975.99 in 2022, indicating a reduction of about 10.5%[37]. - Research and development expenses for the first nine months of 2023 were CNY 11,583,958.02, up from CNY 8,452,158.86 in 2022, indicating an increase of approximately 37.5%[38]. - The company reported a financial expense reduction, with interest expenses decreasing from CNY 2,627,030.24 in 2022 to CNY 811,217.40 in 2023, a decline of about 69%[38]. Shareholder Information - The total number of unrestricted shares increased from 28,394,210 to 30,594,210, representing 34.58% of total shares by the end of the period[17]. - The total number of restricted shares decreased from 60,088,500 to 57,888,500, accounting for 65.42% of total shares by the end of the period[17]. - The total share capital remained unchanged at 88,482,710 shares[17]. - The number of shareholders holding common stock is 4,438[17]. - The largest shareholder, Pan Rulong, holds 19,180,000 shares, representing 21.68% of total shares[19]. - The second-largest shareholder, Xiong Xinguo, holds 10,500,000 shares, accounting for 11.87% of total shares[19]. - The total shares held by the top ten shareholders amount to 67,481,117, which is 76.27% of total shares[19]. - The company has implemented an employee stock ownership plan, issuing 2,708,500 shares at a price of 2 yuan per share[24]. Legal and Other Matters - There are no significant legal disputes or external guarantees reported during the period[23]. - The company has pledged assets totaling 29,996,776.53 yuan, which is 5.57% of total assets[26]. Inventory and Construction - Inventory decreased to CNY 55,648,668.55 from CNY 72,322,835.62, a decline of about 23.0%[29]. - The company has ongoing construction projects with capitalized costs of CNY 30,295,121.97, up from CNY 25,366,351.39, indicating a growth of approximately 19.1%[30]. - Deferred tax assets decreased to CNY 1,107,799.27 from CNY 1,415,031.49, a decline of about 21.7%[30]. - Short-term borrowings significantly decreased to CNY 970,964.00 from CNY 38,814,375.00, a drop of approximately 97.5%[30]. - The company reported a decrease in accounts receivable to CNY 50,759,395.20 from CNY 48,291,152.53, an increase of about 5.1%[29]. Future Outlook - The company plans to continue focusing on market expansion and new product development to drive future growth[36]. - The company plans to continue focusing on investment activities, as indicated by the significant cash outflows for investments in the first nine months of 2023[44].
大宗交易(京)
2023-10-27 12:28
| 日期 | 代码 | 简称 | 成交价 | 成交数量(股) | 买入营业部 | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2023-10- | | | | | 光大证券股份有限公 | 中国银河证券股份有 | | 27 | 832982 | 锦波生物 | 157.78 | 100000 | 司北京月坛北街营业 | 限公司太原南中环街 | | | | | | | 部 | 证券营业部 | | 2023-10- | | | | | 中信证券股份有限公 | 中国银河证券股份有 | | 27 | 832982 | 锦波生物 | 157.78 | 163000 | | 限公司太原南中环街 | | | | | | | 司山西分公司 | 证券营业部 | | 2023-10- | 832982 | 锦波生物 | 157.78 | 100000 | 中信证券股份有限公 | 中国银河证券股份有 限公司太原南中环街 | | 27 | | | | | 司山西分公司 | | | | | | | | | 证券营业部 | | 2023-10- | | | | | 山西证券股份 ...
大宗交易(京)
2023-10-24 11:47
| 日期 | 代码 | 简称 | 成交价 | 成交数量(股) | 买入营业部 | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2023-10- | | | | | 华泰证券股份有限公 | 申万宏源西部证券有 | | 24 | 831152 | 昆工科技 | 11.38 | 160000 | 司成都人民南路证券 | 限公司霍尔果斯亚欧 | | | | | | | 营业部 | 路证券营业部 | | 2023-10- | | | | | 中国银河证券股份有 | 中国中金财富证券有 | | 24 | 832089 | 禾昌聚合 | 8.2 | 250000 | 限公司北京中关村大 | 限公司北京科学院南 | | | | | | | 街证券营业部 | 路证券营业部 | | 2023-10- | | | | | 中国中金财富证券有 | 中信建投证券股份有 | | 24 | 832978 | 开特股份 | 9.75 | 123782 | 限公司北京科学院南 | 限公司无锡中山路证 | | | | | | | 路证券营业部 | 券营业部 | | 2023-10- ...
大宗交易(京)
2023-10-19 12:07
| 日期 | 代码 | 简称 | 成交价 | 成交数量(股) | 买入营业部 | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2023-10- | | | | | 国联证券股份有限公 | 中信证券股份有限公 | | 19 | 836422 | 润普食品 | 3.57 | 280000 | 司无锡梁溪路证券营 | 司上海万源路证券营 | | | | | | | 业部 | 业部 | | 2023-10- | | | | | 招商证券股份有限公 | 招商证券股份有限公 | | 19 | 833533 | 骏创科技 | 11.85 | 84400 | 司北京朝外大街证券 | 司北京知春东里证券 | | | | | | | 营业部 | 营业部 | ...
大宗交易(京)
2023-10-16 11:42
| 日期 | 代码 | 简称 | 成交价 | 成交数量(股) | 买入营业部 | 卖出营业部 | | --- | --- | --- | --- | --- | --- | --- | | 2023-10- | 832982 | 锦波生物 | 139.1 | 30000 | 华泰证券股份有限公 | 申万宏源证券有限公 | | 16 | | | | | 司北京西三环国际财 | 司青岛分公司 | | | | | | | 经中心证券营业部 | | | 2023-10- | 832982 | 锦波生物 | | | 华泰证券股份有限公 司北京西三环国际财 | 中泰证券股份有限公 司青岛正阳路证券营 | | 16 | | | 139.1 | 20000 | | | | | | | | | 经中心证券营业部 | 业部 | | 2023-10- | 832982 | 锦波生物 | 139.1 | | 华泰证券股份有限公 司北京西三环国际财 | 中泰证券股份有限公 司青岛正阳路证券营 | | 16 | | | | 50000 | | | | | | | | | 经中心证券营业部 | 业部 | | 2023-10- | 8334 ...